Stroke is a neurological insufficiency marked by an acute focal injury to the central nervous system due to vascular causes which also includes cerebral infarction, intracranial haemorrhage along with subarachnoid haemorrhage. To assess the prescribing pattern in the management of stroke at a tertiary care hospital. A prospective observational study was carried out for a period of 6 months in both ischemic and hemorrhagic stroke patients with age group between 18 – 90 years. Patient demographic and other data’s were collected using a specially designed data collection form. The Modified rankin scale was used to measure the severity of stroke. All the data was analyzed using graphpad. A total of 100 patients were enrolled in the study. Male gender (60%) was more prone to stroke, majorly in the age group of 60-80 years of age along with the social risk factors like tobacco (21%) and smoking (20%). Hypertension (52.38) was found as a dominant past medical history in stroke patients. The prescribing pattern in the management of stroke were appropriate to the condition of the patient which comprises of anti-platelets (27%), anti-lipidemic (26%), anti-hypertensive (26%) and other medications for the treatment of the comorbid conditions such as hypertension (52%), diabetes (17%), dyslipidemia and other conditions. The duration of stay (22 days) is directly proportional to the extent of disability of the patient as well as the comorbidities which invariably increases the cost of therapy. The direct medical cost was found to be linearly proportional to the extent of disability and comorbid condition of the patient. Cerebrovascular stroke is a crucial public health problem and thus it is vital to monitor the prescribing patterns and its management. The need of clinical pharmacist is needed to facilitate recovery of the patient and enhance the healthcare experience along with reducing the economic burden and length of stay in hospital so as to decrease morbidity and mortality.

Keywords : Stroke, Prescribing Pattern, Management, Modified Rankin Scale, Hypertension, Cost.